US EditionContext Therapeutics Names Dr. Karen Chagin as Chief Medical Officer
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Context Therapeutics Names Dr. Karen Chagin as Chief Medical Officer
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Dr. Karen Chagin, M.D. as Chief Medical Officer (CMO), effective June 9, 2025. Dr. Chagin will succeed Dr. Karen Smith, M.D., Ph.D., MBA, LLM, who has served as interim CMO. Dr. Smith will continue to contribute as a member of the company’s Board of Directors. Dr. Chagin joins Context with more than a decade of experience in clinical development and regu…
Cardinale Smith Named Inaugural Chief Medical Officer at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) announced that Cardinale Smith, MD, PhD, has joined the institution as the inaugural Chief Medical Officer (CMO).
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
